Trigr Therapeutics

Compass inks Trigr takeover to land clinical-phase bispecific
Fierce Biotech
Fri, 05/14/21 - 11:04 am
Compass Therapeutics
bispecific antibodies
M&A
Trigr Therapeutics
solid tumors